Drug Profile
Research programme: mitochondrial disease therapeutics - ElexoPharm/Khondrion/Pharmacelsus/Radboud University
Alternative Names: E!6654; MITOTREATLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator ElexoPharm GmbH; Khondrion; Pharmacelsus; Radboud University Nijmegen Medical Centre
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mitochondrial disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Mitochondrial disorders in Germany
- 24 Jul 2016 Early research is ongoing in Germany and the Netherlands